Search Results - Hiroshi Masumoto

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report by Ryo Takada, Miki Fujiwara, Masatoshi Maki, Naoyuki Nomura, Shintaro Kono, Akira Fujita, Hiroshi Masumoto, Yoko Takahashi, Yasuhisa Hasegawa, Koji Tamura

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: